*PVP - Multi-Center preliminary data as published in Journal of Urology, AUA Abstract Book 2003 (n=12). Final data will differ based on greater patient sample at 1-year follow-up.
A new minimally invasive "Gold Standard"?
Half a century. For this entire period, TURP has held the title of "Gold Standard" for the treatment of BPH. Until now this title has remained unchallenged. Now, only GreenLight PVP™ can deliver the clinical efficacy of TURP in a low risk, minimally invasive treatment. GreenLight PVP™ (photoselective vaporisation of the prostate) is changing the treatment course of BPH.
Exceptional clinical results
Results that are comparable, or surpass TURP results without complications
The results for Qmax, post-void residual values and symptoms scores are better than any other minimal invasive treatment
Multi-Center studies document sustained and reproducible results
The haemostatic properties of a 532nm wavelength result in a virtually bloodless procedure
Widest patient selection
Small and large glands
Patients on anticoagulants
Patients in retention
Patients with enlarged median lobes
Local, spinal or general anaesthesia
In the future, possible outpatient procedure
Low risk of complications
Little or no catheterisation
Return to everyday life within 48 hours, if strenuous activities are avoided
No re-treatments reported in a 5-year follow-up period